ASO Author Reflections: Should we Change the Indication for Thoracic Duct Resection Based on the Response to Neoadjuvant Chemotherapy?
Ann Surg Oncol
.
2024 Oct 28.
doi: 10.1245/s10434-024-16413-3.
Online ahead of print.
Authors
Satoru Matsuda
1
,
Hiroya Takeuchi
2
,
Ken Kato
3
,
Yuko Kitagawa
1
Affiliations
1
Department of Surgery, Keio University School of Medicine, Tokyo, Japan.
2
Department of Surgery, Hamamatsu University School of Medicine, Hamamatsu, Japan. htakeuchi@a6.keio.jp.
3
Department of Head and Neck and Esophageal Medical Oncology, National Cancer Center Hospital, Tokyo, Japan.
PMID:
39467969
DOI:
10.1245/s10434-024-16413-3
No abstract available